Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles von Hasanzadeh Kafshgari, M, Alnakhli, M, Delalat, B, Apostolou, S, Harding, F J, Mäkilä, E, Salonen, J J, Kuss, B J, Voelcker, N H

Volltext

P669: FIXED‐DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST‐LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 3‐YEAR FOLLOW‐UP FROM THE PHASE 2... von Moreno, C., Wierda, W. G., Barr, P. M., Siddiqi, T., Allan, J. N., Kipps, T. J., Trentin, L., Jacobs, R., Jackson, S., Tedeschi, A., Opat, S., Bannerji, R., Kuss, B. J., Croner, L. J., Szafer‐Glusman, E., Zhou, C., Szoke, A., Dean, J. P., Ghia, P., Tam, C. S.

Volltext

Clinical utility of molecular and flow cytometric markers in chronic lymphocytic leukaemia von Sulda, M. L., Kuss, B. J., Hall, R. K., Bailey, S., Macardle, P. J.

Volltext

Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications von Kuss, B.J, Eyre, H.J, Lane, S.A, Nancarrow, J.K, Whitmore, S.A, Callen, D.F, Deeley, R.G, Cole, S.P.C, Willman, C.L, Kopecky, K.L, Willman, C.L, Kopecky, Kj, Wolman, S.R, Willman, C.L, Kopecky, Kj, Wolman, S.R

Volltext

Antisense - time to shoot the messenger von Kuss, B., Cotter, F.

Volltext

AN IMPROVED BENEFIT‐RISK PROFILE OF DUVELISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WHO RECEIVED 2 OR MORE PRIOR THERAPIES von Flinn, I.W., Davids, M.S., Hillmen, P., Montillo, M., Delgado, J., Kuss, B.J., Tam, C.S., Jäger, U., Ghia, P., Stilgenbauer, S., Lustgarten, S., Weaver, D.T., Youssoufian, H., Cymbalista, F.

Volltext

EFFECT OF DOSE MODIFICATIONS ON RESPONSE TO DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL/SLL IN THE DUO TRIAL von Ghia, P., Flinn, I.W., Lamanna, N., Montillo, M., Illés, Á., Etienne, G., Delgado, J., Kuss, B.J., Tam, C.S., Offner, F., Bosch, F., Davids, M.S., Jäger, U., Cymbalista, F., Weaver, D.T., Lustgarten, S., Youssoufian, H., Stilgenbauer, S.

Volltext

CAPTIVATE PRIMARY ANALYSIS OF FIRST‐LINE TREATMENT WITH FIXED‐DURATION IBRUTINIB PLUS VENETOCLAX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL) von Tam, C. S. L, Allan, J. N, Siddiqi, T, Kipps, T. J, Jacobs, R, Opat, S, Barr, P. M, Tedeschi, A, Trentin, L, Bannerji, R, Jackson, S, Kuss, B, Moreno, C, Szafer‐Glusman, E, Russell, K, Zhou, C, Ninomoto, J, Dean, J. P, Ghia, P, Wierda, W. G

Volltext

ARA,a Novel ABC Transporter, Is Located at 16p13.1, Is Deleted in inv(16) Leukemias, and Is Shown To Be Expressed in Primitive Hematopoietic Precursors von Kuss, B.J, O'Neill, G.M, Eyre, H, Doggett, N.A, Callen, D.F, Davey, R.A

Volltext

PF393 A RANDOMISED JOINT AUSTRALASIAN (ALLG) AND FRENCH (FILO) STUDY OF LENALIDOMIDE CONSOLIDATION IN PATIENTS WITH RESIDUAL CLL AFTER FRONT‐LINE TREATMENT WITH FC/FCR (THE CLL6 TR... von Gottlieb, D., Aurran‐Schleinitz, T., Mulligan, S., Letestu, R., Sartor, M., Bene, M., Kuss, B., Delepine, R., Nguyen, U., Butcher, B., Dreyfus, F., Tam, C., Cymbalista, F.

Volltext

PF388 HAT‐PCR IS MORE SENSITIVE THAN FLOW FOR QUANTIFYING MRD IN CHRONIC LYMPHOCYTIC LEUKEMIA von Morley, A., Latham, S., Hughes, E., Kuss, B., Grist, S., Hall, R., Tam, C., Carney, D., Cull, G., Mulligan, S., Bailey, S., Sartor, M., Gottlieb, D.

Volltext

PS1157 EFFECT OF DOSE MODIFICATIONS ON RESPONSE TO DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL/SLL IN THE DUO TRIAL von Ghia, P., Flinn, I., Lamanna, N., Montillo, M., Illés, Á., Etienne, G., Delgado, J., Kuss, B., Tam, C., Offner, F., Bosch, F., Davids, M., Jäger, U., Cymbalista, F., Weaver, D., Lustgarten, S., Youssoufian, H., Stilgenbauer, S.

Volltext

Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticlesElectronic supplementary information (ESI) available: SEM and TEM images, IRS study, b... von Hasanzadeh Kafshgari, M, Alnakhli, M, Delalat, B, Apostolou, S, Harding, F. J, Mäkilä, E, Salonen, J. J, Kuss, B. J, Voelcker, N. H

Volltext

The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias von Kuss, Bryone J., Deeley, Roger G., Cole, Susan P. C., Willman, Cheryl L., Kopecky, Kenneth J., Wolman, Sandra R., Eyre, Helen J., Callen, David F.

Volltext

Optimal oxygen delivery in critically ill patients von Reinhart, K, Hannemann, L, Kuss, B

Volltext

High Dose Hydroxyurea in Collection of Philadelphia Chromosome-Negative Stem Cells in Chronic Myeloid Leukaemia von Kuss, B. J., Sage, R. E., Shepherd, K. M., Hardingham, J., Nicola, M.

Volltext

Chronic lymphocytic leukaemia Australasian consensus practice statement von Anderson, M.A, Bennett, R, Badoux, X, Best, G, Chia, N, Cochrane, T, Cull, G, Crassini, K, Harrup, R, Jackson, S, Kuss, B, Lasica, M, Lew, T.E, Marlton, P, Opat, S, Palfreyman, E, Polizzotto, M.N, Ratnasingam, S, Seymour, J.F, Soosapilla, A, Talaulikar, D, Tam, C.S, Weinkove, R, Wight, J, Mulligan, S.P

Volltext bestellen

Improving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry von Anderson, MA, Berkahn, L, Cheah, C, Dickinson, M, Gandhi, MK, Giri, P, Hawkes, EA, Johnston, A, Keane, C, McQuilten, ZK, Mulligan, SP, Opat, S, Talaulikar, D, Trotman, J, Williams, J, Wood, EM, Armytage, T, Barraclough, A, Carradice, D, Chong, G, Cochrane, T, Hamad, N, Ku, M, Lee, D, Morgan, S, Mutsando, H, Narayana, M, Prince, HM, Ratnasingam, S, Wight, J, Badoux, X, Cull, G, Kuss, B, Marlton, P, Tam, C, Casan, J, Cushion, T, Tedjaseputra, A, Birch, S, Brown, C, Ellis, D, Harvey, Y, Hitchins, S, Jain, S, Jessup, P, Juneja, S, Kearney, D, Kumar, B, Lade, S, Lee, K, Leslie, C, Long, E, Morey, A, Nath, L, Norris, D, Parker, A, Parry, J, Chen, FP-Y, Chung, E, Morison, J, Rowsell, L, St George, G, Thu, C, Waters, N, Wellard, C, Zheng, M

Volltext bestellen

In vitro and in vivo downregulation of MRP1 by antisense oligonucleotides: A potential role in neuroblastoma therapy von Kuss, Bryone J., Corbo, Margherita, Lau, Wen Min, Fennell, Dean A., Dean, Nicholas M., Cotter, Finbarr E.

Volltext

Ibrutinib plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia : Primary Analysis Results from the Minimal Residual Disease Cohort of the Randomized Phase II CA... von Wierda, W. G, Allan, J. N, Siddiqi, T, Kipps, T. J, Opat, S, Tedeschi, Alessandra, Badoux, X. C, Kuss, B. J, Jackson, S, Moreno, Carol, Jacobs, R. M. D, Pagel, J. M, Flinn, I, Pak, Y, Zhou, Cathy, Szafer-Glusman, E, Ninomoto, J, Dean, James P, James, D. F, Ghia, Paolo, Tam, C. S, Universitat Autònoma de Barcelona

Volltext bestellen